Inhibitory effect of valves on endothelium-dependent relaxations to calcium ionophore in canine saphenous vein

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Eguchi, Daihiko ^a   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

Author keywords

1H 1,2,4 oxadiazolo 4,3 a quinoxalin 1 one; Graft failure; Guanosine cyclic 5 monophosphate; Indomethacin; NG nitro L arginine methyl ester; Venous valve

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE METHYL ESTER; CALCIMYCIN; CALCIUM IONOPHORE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR;

AMINO ACID SYNTHESIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; VEIN DILATATION; VEIN VALVE;

EID: 0035000101     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h892     Document Type: Article

References (24)

1. Berczi V, Greene AS, Dornyei G, Csengody J, Hodi G, Kadar A, and Monos E. Venous myogenic tone: studies in human and canine vessels. Am J Physiol Heart Circ Physiol 263: H315-H320, 1992.
2. Blochl-Daum B, Schuller-Petrovic S, Wolzt M, Korn A, Bohler K, and Eichler HG. Primary defect in alpha-adrenergic responsiveness in patients with varicose veins. Clin Pharmacol Ther 49: 49-52, 1991.
3. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, and Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
4. Bracamonte MP, Burnett JC Jr, and Miller VM. Activation of soluble guanylate cyclase and potassium channels contribute to relaxations to nitric oxide in smooth muscle derived from canine femoral veins. J Cardiovasc Pharmacol 34: 407-413, 1999.
5. Bradley KK, Buxton IL, Barber JE, McGaw T, and Bradley ME. Nitric oxide relaxes human myometrium by a cGMP-independent mechanism. Am J Physiol Cell Physiol 275: C1668-C1673, 1998.
6. Chaux A, Ruan XM, Fishbein MC, Sandhu M, and Matloff JM. Influence of vein valves in the development of arteriosclerosis in venoarterial grafts in the rabbit. J Thoracic Cardiovasc Surg 110: 1381-1389, 1995.
7. De Mey JG and Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res 51: 439-47, 1982.
8. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, and Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 79: 124-129, 1989.
9. El Khatib H, Lupinetti FM, Sanofsky SJ, and Behrendt DM. Production of endothelium-dependent relaxation responses by saphenous vein grafts in the canine arterial circulation. Surgery 110: 523-528, 1991.
10. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang ZH, Turina M, Gradel E, Weber E, and Buhler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med 319: 462-467, 1988.
11. Mills JL, Fujitani RM, and Taylor SM. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five-year prospective study. J Vasc Surg 17: 195-204, 1993.
12. Mills NL. Saphenous vein graft valves: "the bad guys." Ann Thorac Surg 48: 613-614, 1989.
13. Moody AP, Edwards PR, and Harris PL. The aetiology of vein graft strictures: a prospective marker study. Eur J Vasc Surg 6: 509-511, 1992.
14. 13a. Nemcova S, Gloviczki P, Rud KS, and Miller VM. Cyclic nucleotides and production of prostanoids in human varicose veins. J Vasc Surg 30: 876-884, 1999.
15. Pearson PJ, Evora PR, Discigil B, and Schaff HV. Hypoxia increases vasodilator release from internal mammary artery and saphenous vein grafts. Ann Thorac Surg 65: 1220-1225, 1998.
16. Rizzi A, Quaglio D, Vasquez G, Mascoli F, Amadesi S, Calo G, Regoli D, and Zamboni P. Effects of vasoactive agents in healthy and diseased human saphenous veins. J Vasc Surg 28: 855-861, 1998.
17. Schuller-Petrovic S, Siedler S, Kern T, Meinhart J, Schmidt K, and Brunner F. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis. Br J Pharmacol 122: 772-778, 1997.
18. Seidel CL and LaRochelle J. Venous and arterial endothelia: different dilator abilities in dog vessels. Circ Res 60: 626-630. 1987.
19. Simonet S, Bonhomme E, Laubie M, Thurieau C, Fauchere JL, and Verbeuren TJ. Venous and arterial endothelial cells respond differently to throjabin and its endogenous receptor agonist. Eur J Pharmacol 216: 135-137, 1992.
20. Singh RN. Flow disturbance due to venous valves: a cause of graft failure Cathet Cardiovasc Diagn 12: 35-38, 1986.
21. Suthamnatpong N, Maehara T, Kanada A, Takeuchi T, and Hata F. Dissociation of cyclic GMP level from relaxation of the distal, but not the proximal colon of rats. Jpn J Pharmacol 62: 387-393, 1993.
22. Tsutsui M, Milstien S, and Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res 79: 336-342, 1996.
23. Vidal M, Vanhoutte PM, and Miller VM. Dissociation between endothelium-dependent relaxations and increases in cGMP in systemic veins. Am J Physiol Heart Circ Physiol 260: H1531-H1537, 1991.
24. Walsh DB, Downing S, Ahmed SW, and Wallace RB. Valvular obstruction of blood flow through saphenous veins. J Surg Res 42: 39-42, 1987.